China Deploys 120 Humanoid Robots as Interns and UBTECH Moves to Mass Production

Why It Matters

The deployment of over a hundred humanoid interns signals that Chinese manufacturers are moving beyond experimental pilots toward systematic integration of collaborative robots. By pairing on‑site training with a mass‑supply pipeline, UBTECH is creating a feedback loop that accelerates hardware improvements and reduces costs, potentially reshaping labor dynamics in high‑mix, low‑volume production lines. For the global robotics market, China’s coordinated push could set a new benchmark for scale. If the Walker S2 series proves reliable in demanding automotive and battery‑cell environments, other OEMs may accelerate their own humanoid programs, intensifying competition with Western players such as Boston Dynamics and FANUC, and prompting a wave of standards around safety, data sharing and workforce upskilling.

Key Takeaways

• UBTECH and Dongfeng Liuzhou Motor placed >120 Walker S1 robots as interns in a Guangxi factory.
• UBTECH reported 2025 revenue of 2.01 bn yuan ($281 m), a 53.3% YoY increase.
• Sales of large humanoid robots jumped to 821 m yuan ($115 m), 22× growth YoY.
• Walker S2 entered mass delivery with annual capacity >6,000 units, 1,079 units shipped in 2025.
• UBTECH’s gross margin rose to 37.7% and net loss fell 31.9% to 790 m yuan ($111 m).

Pulse Analysis

China’s aggressive rollout of humanoid interns reflects a strategic gamble: use large‑scale data collection to overcome the perception and manipulation challenges that have long limited robot adoption in unstructured environments. By embedding robots in real production lines, UBTECH can iterate hardware and software faster than competitors that rely on isolated labs. The partnership with Siemens adds a layer of industrial software expertise, ensuring that the visual navigation stack can be integrated with existing MES and ERP systems.

Financially, UBTECH’s shift from a loss‑making startup to a profitable, high‑margin player underscores the economics of scale. The 22‑fold revenue jump for its humanoid segment suggests that the market is finally moving past proof‑of‑concept. However, the company’s net loss remains sizable, indicating that heavy R&D and capital expenditures are still required to sustain the production ramp‑up. Investors will watch whether the 6,000‑unit annual capacity can be filled without sacrificing quality, especially as the firm expands into new verticals like education and corporate services.

Globally, the Chinese model could pressure Western robot makers to accelerate their own humanoid programs. The combination of government‑backed data centers, a clear path to mass production, and a demonstrated demand in automotive and battery factories creates a competitive moat. If UBTECH can maintain its margin improvements while scaling, it may force a re‑evaluation of collaborative‑robot pricing and deployment strategies worldwide, potentially sparking a new wave of joint‑venture agreements and cross‑border technology transfers.